DexCom, Inc.

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 23:00:00 12/06/2025 +03			5-day change	1st Jan Change
82.85 ^USD	-0.17%		-3.37%	+6.53%

06-10	Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users	RE
06-09	GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing	CI

Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users

Published on 10/06/2025 at 17:07

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about DexCom, Inc.

Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users	06-10	RE
GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing	06-09	CI
Jefferies Adjusts Price Target on DexCom to $110 From $105, Maintains Buy Rating	05-30	MT
Goldman Sachs Initiates DexCom at Buy With $104 Price Target	05-30	MT
Citigroup Adjusts Price Target on DexCom to $102 From $82, Maintains Buy Rating	05-22	MT
DexCom Adds President Role to COO Jake Leach	05-13	MT
DexCom, Inc. Announces Promotion of Jake Leach to the Expanded Role of President and COO	05-13	CI
DexCom, Inc. Appoints Renée Galá to Audit and Compensation Committees Effective May 9, 2025	05-09	CI
Insulet beats quarterly profit estimates on insulin pump demand	05-08	RE
Barclays Adjusts DexCom Price Target to $93 From $90, Maintains Equal Weight Rating	05-05	MT
Analyst recommendations: Amazon, PepsiCo, Linde, Pfizer, Crowdstrike Holdings...	05-05
Equities Advance After Jobs Data; Wall Street Notches Back-to-Back Weekly Gains	05-03	MT
Equity Markets Close Higher as April Jobs Data Beats Expectations	05-02	MT
US Equities Markets End Higher Friday as US Adds More Jobs Than Expected	05-02	MT
Sector Update: Health Care Stocks Climb Late Afternoon	05-02	MT
DexCom, Inc. Announces Resignation of Karen Dahut as Director, Effective May 8, 2025	05-02	CI
Sector Update: Health Care	05-02	MT
Equity Markets Rise After Nonfarm Payrolls Beat Expectations	05-02	MT
Jobs Report Helps Boost Equities Intraday; Apple Falls	05-02	MT
Top Midday Gainers	05-02	MT
US Equity Indexes Jump Following Strong Jobs Report, Easing China Trade Tensions	05-02	MT
Canaccord Genuity Adjusts Price Target on DexCom to $106 From $103	05-02	MT
Baird Adjusts Price Target on DexCom to $105 From $115	05-02	MT
BTIG Adjusts Price Target on DexCom to $109 From $107	05-02	MT
Citigroup Adjusts Price Target on DexCom to $82 From $80	05-02	MT

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.7% of net sales.

Employees

10,250

Sector

Medical Equipment, Supplies & Distribution

Calendar

07-24 - Q2 2025 Earnings Release (Projected)

More about the company